Diagnosis and complications of retinal vascular disease developing in preterm children

Diagnosis, treatment and complications of retinopathy of prematurity

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

ISRCTN

Registry ID

ISRCTN18040926

Enrollment

302

Registered

2018-07-24

Start date

2016-02-01

Completion date

Unknown

Last updated

2019-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Retinopathy of prematurity Eye Diseases Retinopathy of prematurity

Interventions

Records were reviewed, using the International Classification of Retinopathy of Prematurity (ICROP) criteria to review diagnoses and the Early Treatment of Retinopathy of Prematurity (ETROP) study gro

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Preterm babies born between 6 and 35 weeks of gestation

Exclusion criteria

Exclusion criteria: N/A

Design outcomes

Primary

Measure	Time frame
The following were measured from birth to the end of the follow-up period: 1. Total maturation of retinal vascularisation 2. IVB (intravitreal bevacizumab) dose 3. LPC (laser photocoagulation) treatment 4. Complications after treatment 5. Stage of ROP 6. Gender of infant 7. Follow-up duration (weeks) 8. Gestational week of birth 9. Incubation duration (days)	—

Countries

Turkey

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Feb 4, 2026